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Purpose: To compare the acute effects of caffeine and placebo ingestion with a control 26 
condition (i.e., no supplementation) on vertical jump performance. 27 
Methods: The sample for this study consisted of 26 recreationally trained males. Following 28 
the familiarization visit, the subjects were randomized in a double-blind fashion to three main 29 
conditions: (a) placebo, (b) caffeine, and (c) control. Caffeine was administered in a gelatin 30 
capsule in the dose of 6 mg∙kg−1 of body weight. Placebo was administered in a gelatin 31 
capsule containing 6 mg∙kg−1 of dextrose. Vertical jump performance was assessed using a 32 
countermovement jump (CMJ) performed on a force platform. Analyzed outcomes were 33 
vertical jump height and maximal power output. 34 
Results: For vertical jump height, we observed significant differences between: (a) placebo 35 
and control conditions (g = 0.13, 95% confidence interval [CI]: 0.03, 0.24; +2.5%); (b) 36 
caffeine and control conditions (g = 0.31, 95% CI: 0.17, 0.50; +6.6%); and, (c) caffeine and 37 
placebo conditions (g = 0.19, 95% CI: 0.06, 0.34; +4.0%). For maximal power output, we did 38 
not find a significant main effect of condition (p = 0.638). 39 
Conclusions: Ingesting a placebo or caffeine may enhance CMJ performance as compared to 40 
the control condition, with the effects of caffeine vs. control appearing to be greater than the 41 
effects of placebo vs. control. Additionally, caffeine was ergogenic for CMJ height as 42 
compared to placebo. Even though caffeine and placebo ingestion improved vertical jump 43 
height, we did not find any significant effects of condition on maximal power output 44 
generated during take-off.  45 




The acute ergogenic effects of caffeine supplementation on exercise performance are well-48 
established.1-3 Traditionally, the effects of caffeine on exercise performance are explored by 49 
testing the subjects following the ingestion of caffeine on one occasion and placebo on 50 
another. In such a design, it is generally assumed that the placebo condition does not influence 51 
exercise performance. However, Beedie and Foad4 highlighted several instances where 52 
placebo administration had a positive effect on exercise outcomes, and they have suggested to 53 
researchers to include a baseline or control condition in which exercise performance is 54 
evaluated without any supplementation. A comparison of exercise performance following 55 
caffeine or placebo ingestion with a control condition may provide findings that inform two 56 
different domains, that is, the isolated effects of both caffeine and placebo on exercise 57 
performance.4 These recommendations were echoed in a recent consensus statement on 58 
placebo effects in sports and exercise.5 59 
  60 
A recent meta-analysis by Grgic et al.1 reported that caffeine ingestion might acutely enhance 61 
vertical jump height. This finding was obtained by pooling the results from ten individual 62 
studies; however, none of the included studies incorporated a control condition (i.e., studies 63 
only compared the effects of caffeine vs. placebo). Similarly, a meta-analysis by Salinero et 64 
al.3 also reported ergogenic effects of caffeine on single and repeated jump height, but again, 65 
all studies that provided isolated caffeine included only caffeine and placebo conditions. In 66 
this Brief Report, we compared the acute effects of caffeine and placebo ingestion with a 67 
control condition, on vertical jump performance. We hypothesized that: (a) ingestion of 68 
placebo would improve performance as compared to the control condition, and (b) ingesting 69 





Subjects  73 
A priori power analysis was calculated using G*Power (version 3.1.9.2, University 74 
Düsseldorf, Germany). Assuming ANOVA, repeated measures, within factors as the 75 
statistical test, 0.15 as the expected effect size (f) for vertical jump height, 0.05 as α, the 76 
statistical power of 0.80, 1 group, 3 measurements, and correlation of 0.85 (used from a 77 
previously published dataset6) the power analysis indicated that the required sample size was 78 
n = 23. To account for possible drop-outs, we recruited 26 recreationally trained males (mean 79 
± SD: age 23 ± 2 years; height 183 ± 7 cm; body mass 83 ± 11 kg; habitual caffeine intake: 80 
0.95 ± 1.16 mg·kg-1). All participants were physical education students with resistance 81 
training experience, and some had prior experience in different sports (e.g., basketball, 82 
handball), but none were current competitive athletes. The Committee for Scientific Research 83 
and Ethics of the Faculty of Kinesiology at the University of Zagreb provided ethical approval 84 
for the study (20/09/2018); all subjects provided written informed consent. 85 
 86 
Design 87 
Randomized, crossover, double-blind study design. 88 
 89 
Methodology 90 
The subjects visited our laboratory on four occasions. During the first visit, they filled out the 91 
Food Frequency Questionnaire7 for estimating their habitual caffeine intake and were 92 
familiarized with the exercise test. Then, they were randomized in a counterbalanced fashion 93 
to three main conditions: (a) placebo, (b) caffeine, and (c) control (i.e., no supplementation). 94 
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These conditions were separated 3-6 days. Caffeine was administered in a gelatin capsule in 95 
the dose of 6 mg∙kg−1. The placebo was administered in a gelatin capsule containing 6 96 
mg∙kg−1 of dextrose. To ensure adequate blinding, all administered capsules were of identical 97 
appearance and taste. The testing was carried out 60 minutes after capsule ingestion. In the 98 
control condition, the participants did not ingest any capsule, but the waiting time, until the 99 
exercise session started, was also 60 minutes. Testing sessions were performed between 07:00 100 
and 09:00 am with the subjects in a fasted state (overnight fast). The effectiveness of the 101 
blinding was explored as described by Saunders et al.8 102 
 103 
Fifty minutes after supplement ingestion, the participants performed 10 minutes of self-104 
selected warm-up. The participants were instructed to keep to warm-up consistent in each 105 
session. Vertical jump testing was performed on a force platform (BP600600, AMTI, Inc., 106 
Watertown, MA, USA), accompanied with a custom-developed software for data acquisition 107 
and analysis. In each testing session, the subjects performed three countermovement jumps 108 
(CMJ) on this platform, with a detailed procedure explained elsewhere.9,10 The best jump was 109 
used for the analysis. The analyzed outcomes were vertical jump height (cm) calculated from 110 
the vertical velocity of the center of mass at take-off data,11 and maximal power output during 111 
take-off (W∙kg-1). Earlier test-retest reliability assessment in our laboratory yielded the 112 
coefficient of variation (CV) of 1.3% for the CMJ height and 1.4% for maximal power output.  113 
 114 
Statistical analysis 115 
The differences between the three conditions (i.e., caffeine, placebo, and control) in the 116 
analyzed variables (i.e., vertical jump height and maximal power output) were examined by a 117 
one-way repeated measures ANOVA. If significant main effects were observed, pairwise 118 
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comparisons of conditions were explored by a paired t-test. The statistical significance 119 
threshold was initially set at p < 0.05; however, to account for multiple comparisons, we used 120 
the Holm-Bonferroni correction. Effect sizes (Hedges’ g; ES) and 95% confidence intervals 121 
(95% CI) for repeated measures were calculated, as were the percent differences between the 122 
conditions. ESs of <0.20, 0.20–0.49, 0.50–0.79, and ≥0.80 were considered as trivial, small, 123 
moderate, and large, respectively. Bang’s Blinding Index12 was used to explore the 124 
effectiveness of the blinding. All analyses were performed using the “Statistica” software 125 
(version 13.4.0.14; TIBCO Software Inc., Palo Alto, CA, USA). Individual participant data 126 
are presented per established recommendations.13  127 
 128 
Results 129 
Vertical jump performance 130 
The results of the one-way repeated measures ANOVA for vertical jump height indicated a 131 
significant main effect of condition, p < 0.001. The pairwise comparisons revealed significant 132 
differences between: (a) placebo and control conditions (p = 0.018; ES = 0.13 [95% CI: 0.03, 133 
0.24]; +2.5%); (b) caffeine and control conditions (p = 0.0001; ES = 0.31 [95% CI: 0.17, 134 
0.50]; +6.6%); and, (c) caffeine and placebo conditions (p = 0.005; ES = 0.19 [95% CI: 0.06, 135 
0.34]; +4.0%) (Table 1, Table 2). The results of the one-way repeated-measures ANOVA for 136 
maximal power output did not indicate a significant main effect of condition (p = 0.638), and 137 
no post hoc analysis was performed. Within-person variation to the three conditions is 138 
presented in Figure 1. 139 
 140 
Assessment of blinding  141 
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In the pre-exercise evaluation, 23% and 42%, and in the post-exercise evaluation, 31% and 142 
54% of the participants correctly identified the caffeine and placebo conditions beyond 143 
random chance, respectively. 144 
 145 
Discussion 146 
Our results indicate that: (a) ingesting a placebo or caffeine may acutely increase CMJ height 147 
as compared to the control (i.e., no supplementation) condition; and (b) caffeine ingestion 148 
may acutely increase CMJ height as compared to placebo. Even though CMJ height increased 149 
following caffeine and placebo ingestion, we did not find any significant effects of condition 150 
on maximal power output generated during take-off.  151 
  152 
Caffeine ingestion, as compared to both placebo and control, was effective in increasing 153 
vertical jump height. These results are in line with two recent meta-analyses that reported 154 
ergogenic effects of caffeine on vertical jump height, in comparison to placebo.1,3 Moreover, 155 
even the ES of 0.19 observed in this study closely matches the pooled ES in the two meta-156 
analyses1,3 (ESs of 0.17 and 0.19, respectively). Administering a placebo (as compared to 157 
control) was also ergogenic for increasing vertical jump height. These results suggest that 158 
providing a placebo when seeking acute improvements in jumping performance may be an 159 
option. However, caution is warranted here as providing a placebo may be ethically 160 
problematic and may result in issues of trust between the practitioner and client.4  161 
 162 
In a recent consensus statement on placebo effects in sports and exercise,5 the authors noted 163 
that, in many cases, the placebo effects are of a similar magnitude as the effects of the actual 164 
treatment (in this case, caffeine). Given the results of the present study, this may be true to an 165 
extent, but only if we compare the effects of caffeine vs. placebo (ES = 0.19: +4.0%) with the 166 
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effects of placebo vs. control (ES = 0.13; +2.5%). However, the same cannot be stated in the 167 
comparison of the effects of caffeine vs. control given that here, the ES magnitude was greater 168 
and amounted to 0.31 (+6.6%). While placebo may lead to increased vertical jump height, the 169 
effects of caffeine seem to be greater than the effects of placebo, even though it needs to be 170 
mentioned that there was a small degree of overlap between the 95% CIs in these 171 
comparisons. This is important from a practical perspective if we consider that an individual 172 
interested in supplementing with this ergogenic aid will either ingest or simply not ingest 173 
caffeine (i.e., the deliberate use of a placebo is much less likely to occur). From a research 174 
perspective, this suggests that studies using a double-blind study design without a control 175 
session might underestimate the effect of caffeine given that the actual effect may be greater 176 
than that shown in comparison with a placebo condition. 177 
 178 
Studies that reported increases in vertical jump height following caffeine ingestion commonly 179 
interpret these results as improvements in ‘power’.1 However, as we demonstrate in this 180 
study, vertical jump height might change following caffeine ingestion even though maximal 181 
power output remains relatively similar across all conditions. This finding is in line with a 182 
recent paper suggesting that vertical jump height might not be a good indicator of lower limb 183 
power/maximal power output capability.14 Therefore, we further reinforce the notion that 184 
changes in vertical jump height might not mirror those observed for muscular power.14 For a 185 
more detailed insight on the issue, readers are referred to the paper by Morin et al.14  186 
  187 
The strengths of this study are the use of a double-blind study design, the addition of a control 188 
condition, relatively effective blinding of the participants, and the inclusion of a large sample 189 
size (allowing for detection of small, but potentially meaningful differences between 190 
conditions). The limitation is that subjects’ expectancy of caffeine, that is, their belief in the 191 
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caffeine’s ergogenic effects,5 was not explored. This needs to be acknowledged, given that 192 
individual expectancy is one of the possible reasons that might explain the placebo effect on 193 
exercise performance.5  194 
  195 
Practical applications 196 
When seeking acute improvements in vertical jump performance, both caffeine and placebo 197 
provided in isolation may be ergogenic; however, the effects of caffeine seem to be greater 198 
than the effects of placebo.  199 
 200 
Conclusions 201 
Ingesting a placebo may improve vertical jump height as compared to no supplementation, 202 
and ingesting caffeine may improve vertical jump height as compared to both the placebo and 203 
no supplementation. Interpreting any changes in vertical jump height following caffeine 204 
ingestion as changes in ‘power’ should be done with caution. As we show herein, vertical 205 
jump height following caffeine ingestion may change without any evident changes in 206 
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Figure 1 — Within-person variation in responses to the 3 conditions (caffeine, placebo, and 254 
control) for (A) vertical jump height and (B) maximal power output during take-off. 255 
 256 
 257 
  258 
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Table 1. Vertical Jump Data in the 3 Conditions 259 
Variable Caffeine condition  Placebo condition Control condition  
Vertical jump height, 
cm 




79.7 (12.6) 81.2 (11.8) 81.5 (10.9) 
Note. Data are reported as mean (SD). 
 260 
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Placebo vs control 0.018 3 0.05 
Caffeine vs placebo 0.005 2 0.025 
Caffeine vs control 0.0001 1 0.017 
 264 
